CATENA

Welcome to the Brand page for “CATENA”, which is offered here for The mark consists of a circle design that contains a smaller circle to the right inside of the original circle. the circle design is followed by the word catena.;pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, and muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, lou gehrig's disease, parkinson's disease, huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies;color is not claimed as a feature of the mark.;chemicals for use in industry and science; reagents for scientific and medical research use;medical research; science research; medical and scientific research, conducting clinical trials; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; animal model testing and research for neuro-muscular and ophthalmological diseases;.

Its status is currently believed to be active. Its class is unavailable. “CATENA” is believed to be currently owned by “Santhera Pharmaceuticals (Schweiz) AG”.